Ting‐Miao Wu

611 total citations
17 papers, 378 citations indexed

About

Ting‐Miao Wu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ting‐Miao Wu has authored 17 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Ting‐Miao Wu's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Ting‐Miao Wu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Ting‐Miao Wu collaborates with scholars based in China. Ting‐Miao Wu's co-authors include Yu‐Shui Ma, Da Fu, Ji‐Bin Liu, Huiqiong Yang, Yi Shi, Fei Yu, Gao‐Ren Wang, Zhijun Wu, Huimin Wang and Li‐Peng Gu and has published in prestigious journals such as PLoS ONE, Oncotarget and Journal of Cellular and Molecular Medicine.

In The Last Decade

Ting‐Miao Wu

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ting‐Miao Wu China 12 275 245 48 47 31 17 378
Zhiqi Yao China 4 260 0.9× 276 1.1× 39 0.8× 71 1.5× 38 1.2× 4 383
Jin-Hai Tang China 6 207 0.8× 173 0.7× 36 0.8× 57 1.2× 53 1.7× 12 315
Mengna Zhan China 9 253 0.9× 201 0.8× 51 1.1× 77 1.6× 34 1.1× 13 367
Ana Lameirinhas Portugal 12 269 1.0× 188 0.8× 25 0.5× 72 1.5× 54 1.7× 18 386
Zining Jin China 11 186 0.7× 136 0.6× 25 0.5× 74 1.6× 61 2.0× 28 309
Diyu Hou China 10 213 0.8× 114 0.5× 42 0.9× 57 1.2× 22 0.7× 17 334
Reham Helwa Egypt 9 210 0.8× 99 0.4× 48 1.0× 75 1.6× 49 1.6× 19 322
Florinda Meléndez‐Rodríguez Spain 6 170 0.6× 135 0.6× 37 0.8× 38 0.8× 47 1.5× 6 280

Countries citing papers authored by Ting‐Miao Wu

Since Specialization
Citations

This map shows the geographic impact of Ting‐Miao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Miao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Miao Wu more than expected).

Fields of papers citing papers by Ting‐Miao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Miao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Miao Wu. The network helps show where Ting‐Miao Wu may publish in the future.

Co-authorship network of co-authors of Ting‐Miao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Miao Wu. A scholar is included among the top collaborators of Ting‐Miao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Miao Wu. Ting‐Miao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Liu, S. L., et al.. (2021). Non-invasive assessment of cerebrospinal fluid flow dynamics using phase-contrast magnetic resonance imaging in communicating hydrocephalus. Journal of Clinical Neuroscience. 93. 116–121. 5 indexed citations
3.
Ma, Yu‐Shui, Ting‐Miao Wu, Chang‐Chun Ling, et al.. (2021). M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B. Molecular Therapy — Oncolytics. 20. 484–498. 85 indexed citations
4.
Ma, Yu‐Shui, Xiao‐Li Yang, Rui Xin, et al.. (2021). The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation. Translational Oncology. 14(8). 101126–101126. 9 indexed citations
5.
Yang, Xiao‐Li, Yi Shi, Dandan Zhang, et al.. (2021). Quantitative proteomics characterization of cancer biomarkers and treatment. Molecular Therapy — Oncolytics. 21. 255–263. 17 indexed citations
6.
Ma, Yu‐Shui, Ting‐Miao Wu, Bin Qian, et al.. (2021). KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation. Journal of Cellular and Molecular Medicine. 25(8). 4040–4052. 23 indexed citations
7.
Fu, Da, Yi Shi, Ji‐Bin Liu, et al.. (2020). Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer. Molecular Therapy — Nucleic Acids. 21. 712–724. 55 indexed citations
8.
Liu, Ji‐Bin, Chang‐Chun Ling, Ting‐Miao Wu, et al.. (2020). Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization. Current Problems in Cancer. 44(6). 100612–100612. 8 indexed citations
9.
Ma, Yu‐Shui, Xiaohui Jiang, Ting‐Miao Wu, et al.. (2020). Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL. Molecular Therapy — Nucleic Acids. 21. 592–603. 25 indexed citations
10.
Wu, Ting‐Miao, Ji‐Bin Liu, Yu Liu, et al.. (2020). Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control. Cancer Control. 27(3). 1148370069–1148370069. 14 indexed citations
11.
Ma, Yu‐Shui, Ji‐Bin Liu, Ting‐Miao Wu, & Da Fu. (2020). New Therapeutic Options for Advanced Hepatocellular Carcinoma. Cancer Control. 27(3). 1148381239–1148381239. 12 indexed citations
12.
Wu, Ting‐Miao, et al.. (2019). Cerebral syphilitic gumma masquerading as cerebral metastatic tumors: case report. Neurosurgical FOCUS. 47(2). E15–E15. 9 indexed citations
13.
Xie, Ruting, Xianling Cong, Xiaoming Zhong, et al.. (2018). MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma. Oncology Letters. 15(4). 4571–4577. 18 indexed citations
14.
Hou, Likun, Yu‐Shui Ma, Yang Han, et al.. (2017). Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy. PLoS ONE. 12(1). e0170431–e0170431. 28 indexed citations
15.
Lu, Gai‐Xia, Da Fu, Chengyou Jia, et al.. (2017). Reduced miR-105-1 levels are associated with poor survival of patients with non‑small cell lung cancer. Oncology Letters. 14(6). 7842–7848. 20 indexed citations
16.
Ma, Yu‐Shui, Ting‐Miao Wu, Zhongwei Lv, et al.. (2017). High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1. Oncotarget. 8(7). 11896–11905. 36 indexed citations
17.
Ma, Yu‐Shui, Likun Hou, Fei Yu, et al.. (2016). Incidence and physiological mechanism of carboplatin-induced electrolyte abnormality among patients with non-small cell lung cancer. Oncotarget. 8(11). 18417–18423. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiqi Yao Breakdown of academic impact, for papers by Jin-Hai Tang Breakdown of academic impact, for papers by Mengna Zhan Breakdown of academic impact, for papers by Ana Lameirinhas Breakdown of academic impact, for papers by Zining Jin Breakdown of academic impact, for papers by Diyu Hou Breakdown of academic impact, for papers by Reham Helwa Breakdown of academic impact, for papers by Florinda Meléndez‐Rodríguez
Rankless by CCL
2026